Key Takeaways Evidence-based therapies for alcohol addiction have scientific validation behind them, making them more ...
TrumpRx has the potential to disrupt the prescription drug market. I want to see it succeed, but it must be structured with care.
Major employers and insurance companies are eliminating coverage for GLP-1 weight-loss drugs. Louisiana families now must ...
4d
Medicaid tries new approach with sickle cell: Companies only get paid if costly gene therapies work
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting ...
Morning Overview on MSN
Gene hacking is coming and it could rewrite what it means to be human
For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...
For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest pact as part of its "Most Favored Nation" pricing initiative.Under the ...
The Department of Health and Human Services appears willing to take its contentious 340B Rebate Model Pilot Model back to the drawing board. After a lawsuit filed by hospitals secured a last-minute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results